Cingulate Inc.
CINGNasdaqCIK 1862150HealthcareFiscal year ends Dec 31
Reports and events: 175 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0220:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-045527 |
| 2026-08-1312:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037606 |
| 2026-08-1312:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037605 |
| 2026-07-2320:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-034402 |
| 2026-07-1412:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-033115 |
| 2026-07-0212:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031668 |
| 2026-06-1612:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028815 |
| 2026-06-0212:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026760 |
| 2026-05-2913:16 ET | DEF 14A | Proxy statementPeriod 2026-05-29 | 0001493152-26-025721 |
| 2026-05-1920:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-024435 |
| 2026-05-1412:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022884 |
| 2026-05-1412:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022881 |
| 2026-04-0220:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-014914 |
| 2026-03-2620:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-011373 |
| 2026-03-2421:14 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results | 0001493152-26-012417 |
| 2026-03-1812:13 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010882 |
| 2026-03-1812:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-010881 |
| 2026-03-0212:00 ET | DEF 14A | Proxy statementPeriod 2026-03-02 | 0001493152-26-008441 |
| 2026-02-1713:10 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006942 |
| 2026-02-0921:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001140361-26-004386 |
| 2026-02-0621:12 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001493152-26-005561 |
| 2026-01-2821:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-004030 |
| 2026-01-1521:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-002417 |
| 2026-01-0221:30 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-000142 |
| 2025-12-1514:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-027667 |
| 2025-11-1322:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022395 |
| 2025-11-1313:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022132 |
| 2025-11-1013:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021410 |
| 2025-10-1412:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017931 |
| 2025-09-2521:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-014963 |
| 2025-09-0521:00 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-25-012753 |
| 2025-08-2821:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-012449 |
| 2025-08-1912:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024744 |
| 2025-08-1912:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024741 |
| 2025-08-1520:30 ET | DEF 14A | Proxy statementPeriod 2025-08-15 | 0001641172-25-024386 |
| 2025-08-1513:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-024286 |
| 2025-08-0811:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-022664 |
| 2025-08-0612:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022360 |
| 2025-07-2520:28 ET | S-1/A | Registration statement, amended | 0001641172-25-021016 |
| 2025-07-2520:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001641172-25-021006 |
| 2025-07-2221:30 ET | S-1 | Registration statement | 0001641172-25-020622 |
| 2025-07-2221:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020618 |
| 2025-06-1111:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-014621 |
| 2025-05-1321:00 ET | 8-K | 1.02 Termination of a material agreement | 0001641172-25-009989 |
| 2025-05-0820:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009289 |
| 2025-05-0820:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009286 |
| 2025-04-2521:00 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001641172-25-006260 |
| 2025-04-0912:13 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-003329 |
| 2025-03-2721:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000970 |
| 2025-03-2613:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000689 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.